Lobe Sciences Establishes Wholly Owned Subsidiary Alera Pharma
Alera will be assigned the intellectual property rights focused on the company’s neurological assets and its new chemical entity Psilocin Mucate.
Alera Pharma | 16/08/2024 | By Aishwarya | 181
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy